One of our pathologists at SNBL, Haruno Yabuki, DVM, received the top honorable mention for a poster she presented at the 35th Scientific Meeting of the Japanese Society of Toxicologic Pathology (JSTP). This meeting is a gathering of nearly all toxicologic pathologists in Japan, whether from pharmaceutical companies or CROs, educational institutions, or public research institutions, and was a great opportunity to show SNBL’s high level of scientific quality.
Congratulations Dr. Yabuki!
For the third year in a row, SNBL Japan received the Health & Productivity Award, presented by the Japanese Ministry of Economy, Trade and Industry. This award recognizes organizations which promote health in their region by implementing strategies to improve the health and productivity of their employees.
As part of its strategy to improve employee health, SNBL Japan has implemented Wellness Tourism seminars, a series of health challenges, and early cancer screenings. SNBL Japan will strive to continue these efforts and ensure that the recognition of our strategy is meaningful.
We have updated our publications section. We look forward to seeing the research that will be presented in 2019.
We will host a joint seminar with Taiwan Research-Based Biopharmaceutical Manufacturers Association (TRPMA) in Taipei on January 23, 2019.
Up to now, drug development in Taiwan has largely operated based on manufacturing contracts; however, successful new drug development has seen an increase in active support from Taiwanese government policy.
SNBL will give lectures to Taiwanese pharmaceutical and biotech companies with the aim of shedding light on the current situation in Japan including topics such as the conduct of GLP studies and GLP monitoring authority in Japan, preclinical studies on biologics and advanced therapy products, and application of imaging techniques to pharmacology and toxicity studies.
This seminar will work to enhance mutual understanding and exchange ideas between Japan and Taiwan in order to facilitate drug development activities in both countries.